View
720
Download
2
Category
Tags:
Preview:
Citation preview
THE BRAZILIAN SWINE INDUSTRY
Maria Nazaré T. Simões LisboaDVM
Campinas São Paulo Brasilnazare@consuitec.com.br
BRAZIL: Great Opportunity in South America
Brazil: Competitive Advantages• Lands availability
• Cost of competitive facilities• Good human resources
• Low production costs (grains)• Good grains production• Strong industrial plant
• PRRS Free• Favorable weather
• Good technology adoption
BRAZILIAN PRODUCTION COST
In Euros $
€ 1,0 – 1,20
SALES COST PER KG OF PIG
In Euros $€ 1,2 – 1,30
Distribution of the Technified Housed Sows
Southeast - 381 thousand dams
Midwest - 273 thousand dams
South - 980 thousand dams
Northeast - 18 thousand dams
North – 2 thousand dams
SC - 420.000RS - 290.000PR - 270.000MG - 241.490SP - 120.000MT- 110.000GO - 100.000MS - 51.749ES - 18.660DF - 11.000CE - 8.000BA - 6.000Other – 7.101Total = 1.654.000
Pork Exports (thousand tons)
Source: ABIPECS, 2011.
Evolution of Pork Brazilian Consumption Per Capita
Beginning of the program to stimulate domestic pork consumption of ABCS (BASP).
Source: ABCS, 2011.
Destination of Pork Production in Brazil in 2007
Destination of Pork Production in Brazil in 2010
Source: ABIPECS, 2011.
83%
17%
Domestic Market International Market
Sows per region in 2010
Source: Abipecs, Sips, Sindicates RS and PR, Embrapa
Number of industrial sows per regionSouthern
RegionSoutheast
RegionMidwest Region
948.055 310.563 216.873
4% increase in 2010
Main Destinations of Brazilian Exports of Pork 2010
Volume: 540.417 ton.
Income: U$$ 1.340.714
Production System of Swine Brazilian Farms
Main producers per category
• Agribusiness;
• Cooperatives;
• Independents
FARMS’ PROFILE Large groups with 26 - 28 weaned/ sow/year Good labor Nº of sow/person between 80 -120 sows The cost of labor is near 8 -12 % in most of the farms Some with costs like 5 – 8%
Several farms are improving their results
Table: Data from farms assisted by Consuitec. Evaluation from the last 12 months (April to March - source Pig Champ).
ISSUES 2005 2006 2007 2008 2009 2010Total Born
11,5 11,9 12,7 13,3 14,4 14,8
Born Alive 10,6 10,7 11,7 12,1 13,0 13,3Weaned 9,4 9,5 10,8 11,4 12,0 12,5
PPU - FARM UPL
NATURAL VENTILATION
CONTROLLED VENTILATION
INTEGRATION (SITE 3)
Biosecurity Measures
LABOR QUALITY
The farrowing are assisted in most of
the pig farms
The weaning age is between 21 – 24 daysWeight = 6,0 -7,0 kg
Depending on the region and market, the animals are sold between 90 and 126 kg of weight
CONCLUSIONS• The costs of production in Brazil are very
competitive• There are a lot of opportunities• It is a growing country• It has a population of de 190 million people
and counting• The purchasing power is improving• There is room for more pork consumption in Brazil and in the world
Efficacy and safety of 0.5ml Circovac® in the control of PCVD (Porcine
Circovirus Disease) under Brazilian field conditions.
“A field observation”
BRAZILIAN SITUATIONPMWS is significant in the 2000 decade.Present in all Brazilian territory.In the beginning autogenous vaccines were used for
a long time.In the first program only sows were vaccinated.Currently there are commercial vaccines that are
used in the control programs: Sows and Piglets
PCVD control is based on:– Nutritional strategies;– Medical strategies;– Management strategies, and above all:
• The use of vaccines can contribute to the effective control of Postweaning Multisystemic Wasting Syndrome -> Great benefits:
Increase productivity;
Sanitary control of affected farms.
CONTROL
A Field Observation
Piglets vaccinated at weaning with 0,5ml Circovac® had lower wasting rates and lower field mortality, showing marked
performance improvement of the vaccinated herd
GOAL
To evaluated Circovac® vaccination effect on:– Wasting rate;– Mortality;– Weight Gain;– Lung Lesions.
NOTE: Animals were naturally challenged with porcine Circovirus type 2 (PCV-2)
Materials and Methods
Evaluations were performed with piglets of different ages, from immunization to
slaughter. Results between the vaccinated and control groups were always compared
This study was one of the various evaluations which supported product claim for piglets in
Brazil in 2008
Animals selection
– 1200 piglets were used, divided into two replicates, subdivided into 2 treatments:
»T1 – Vaccinated group (0,5ml Circovac®) at 21 days of age
»T2 – Non-vaccinated group (control group)
Materials and Methods
Farms selection:
– Each replicate was conducted in a farm with history and confirmed PCVD diagnosis
NOTE: Both with mortality higher than 6% in the last 6 months.
For Circovirus disease confirmation, piglets with clinical signs were euthanized and clinical samples were sent to the lab for histopathological and immunohistochemical tests
Materials and Methods
Treatments/Observations:– 1200 animals randomly allocated into two
groups (30 or 15 animals/pen);– DWG (gaily weight gain), mortality and
wasting rates evaluation -> the experimental unity was each animal;
– FC (Feed conversion) evaluation -> the experimental unity was the pen;
– Feed intake, wasting and mortality rates were weekly evaluated.
Materials and Methods
• Productive parameters evaluated:• Weighing at 65 and 138 days of age (R1) and at 0, 47, 70 and 137 days of age (R2)• DWG (Daily weight gain);• FC (Feed Conversion);• Wasting and mortality rates;• Post-vaccine local or systemic reactions.
• Slaughter evaluation:110 animals randomly selected were evaluated at
slaughter. Half of this number corresponds to vaccinated animals
Materials and Methods
RESULTS : TWG R1 & R2
Figure 1. From 21 to 65 days there was no significant weight gain difference. Although at the final, weight animals from vaccinated group (Circovac®) was bigger( 3,09 Kgs), when compared to the control group.
Figure 1. From 21 to 65 days there was no significant weight gain difference. Although at the final, weight animals from vaccinated group (Circovac®) was bigger( 3,09 Kgs), when compared to the control group.
Weight Gain R1
91,1
26,8 26,8
88,1
0
10
20
30
40
50
60
70
80
90
100
65 138Days
Wei
ght
Vac. groupNon vac. group
RESULTS Replicates 1&2 Total Weight Gain R2
Figure 2. In the evaluated period there was no significant weight gain difference. At day 137 animals from the Circovac® vaccinated group had considerable advantage in feed conversion.
Figure 2. In the evaluated period there was no significant weight gain difference. At day 137 animals from the Circovac® vaccinated group had considerable advantage in feed conversion.
6,815,6
32,7
90,1
6,815,6
32,6
89,7
0102030405060708090
100
0 47 70 137
Days
Wei
ght
Vac. groupNon vac. group
AWG in for both replicates
Figure 5. At weaning and nursery there was no significant difference in the ADG. Later there was an ADG of 37 gr/day more meat for the groups of piglets vaccinated with Circovac®, totaling in the study period to 3,09 Kg for the vaccinated group.
Figure 5. At weaning and nursery there was no significant difference in the ADG. Later there was an ADG of 37 gr/day more meat for the groups of piglets vaccinated with Circovac®, totaling in the study period to 3,09 Kg for the vaccinated group.
RESULTS
Average Daily Gain
0,466
0,8760,839
0,466
00,10,20,30,40,50,60,70,80,9
1
21-65 65-138Period
Aver
age
gain
in k
g/da
y
Vac. groupNon vac. group
Wasting rate•The groups vaccinated with Circovac® showed more uniformity in the batches;
•On replicate 1, the vaccinated group had 5,5% vs. 8%;
•The wasting rate for replicate 2 of the vaccinated group was 9,6% vs. 18% reported for the non vaccinated group;
•The reduction for the control group is inclusive due to the fact that vaccinated animals excrete less virus, reducing the environmental challenge.
RESULTS
Figure 6. In replicate 1 there was no significant statistical difference (P>0,05), only numeric. In replicate 2 there was a statistical difference (p<0,05) in the mortality rate between treatments.
Figure 6. In replicate 1 there was no significant statistical difference (P>0,05), only numeric. In replicate 2 there was a statistical difference (p<0,05) in the mortality rate between treatments.
RESULTS
Rate of Average Mortality1200
70 1110
100
200
300
400
500
600
700
800
900
100011001200
Tota
l de
Ani
maa
ls
Total AnimalsDeaths in vac. groupDeaths in non vac. group
Mortality Rate
Considering the mortality rate of replicate 1, we noticed only a numeric difference between treatments. In replicate 2 the control group lost 30 animals more than the group of piglets vaccinated with Circovac®.
Considering the mortality rate of replicate 1, we noticed only a numeric difference between treatments. In replicate 2 the control group lost 30 animals more than the group of piglets vaccinated with Circovac®.
• Mortality RateDeaths R1 Deaths R2
Treatment Live Dead Treatment Live Dead
T1 576 24 T1 554 46
T2 565 35 T2 524 76
RESULTS
• Lung Lesions and Pneumonia Rate
Índice de lesões pulmonares
78
63
17
32
05
101520253035404550556065707580859095
Sem lesões lesões
Nº d
e a
nim
ais
ab
ati
do
s
Grupo vacinadoGrupo não vacinado
Figure 7. From the 95 slaughtered animals per treatment, the group of piglets vaccinated with Circovac® had 17,9% of lung lesions vs. 33,7% of the control group.
In the further study of lesions, the vaccinated group had less impairment of lung lobes (lower index of pulmonary hepatization lungs).
Some animals from the control group showed pericarditis and adherence (indicating manifestation of secondary agents)
Figure 7. From the 95 slaughtered animals per treatment, the group of piglets vaccinated with Circovac® had 17,9% of lung lesions vs. 33,7% of the control group.
In the further study of lesions, the vaccinated group had less impairment of lung lobes (lower index of pulmonary hepatization lungs).
Some animals from the control group showed pericarditis and adherence (indicating manifestation of secondary agents)
RESULTS
Local reactions
In the assessment of possible post-vaccine local or systemic reactions, no alteration was observed (behavior and body temperature), as well as lack of appetite.
RESULTS
CONCLUSIONSUnder the conditions that the experiments were conducted it was concluded•Between treatments there was no influence in the performance of piglets at pre´-nursery and nursery stages•Weaned piglets vaccinated with 0,5ml Circovac®
intramuscular rout significantly reduced the wasting and mortality rates;•The vaccination of weaned piglets with 0,5ml Circovac® via intramuscular rout increased the average daily gain in 37gr and improved the feed conversion in 100gr of ration/kg of aggregate meat.
• The vaccination of weaned piglets with 0,5ml Circovac® via intramuscular rout did not cause any systemic or local reaction.
• The vaccination of weaned piglets with 0,5ml Circovac® via intramuscular rout decreased significantly pleural and lung lesions at slaughter.
CONCLUSIONS
Thank you forpaying attention
Recommended